MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31, BTCY made $3,987,819 in revenue. -$1,162,614 in net income. Net profit margin of -29.15%.

Income Overview

Revenue
$3,987,819
Net Income
-$1,162,614
Net Profit Margin
-29.15%
EPS
-$0.042
Unit: Dollar
Revenue Breakdown
    • Technology Fees
    • Device Sales

Unit: Dollar
Income Statement
2025-12-31
2025-09-30
2025-06-30
2024-12-31
Revenue
3,987,819 3,885,795 3,873,993 3,619,108
Cost of revenue
736,343 704,297 757,193 855,140
Gross profit
3,251,476 3,181,498 3,116,800 2,763,968
Selling, general and administrative expenses
2,186,994 2,304,881 2,138,692 2,381,734
Research and development expenses
623,567 602,798 696,163 551,216
Total operating expenses
2,810,561 2,907,679 2,834,855 2,932,950
(loss) profit from operations
440,915 273,819 281,945 -168,982
Other income/(expense)
-39,247 106,599 66,671 65,512
Interest expense
810,339 860,419 850,254 -
Gain/(loss) upon convertible promissory notes conversion and redemption note 5
11,409 -8,433 -17,357
Accretion and amortization expenses
-185,470 -202,141 -153,572 -291,128
Interest expense
---849,538
Change in fair value of derivative liabilities note 8
-134,335 -8,771 -25,200 32,339
Net loss before income taxes
-717,067 -690,913 -671,977 -1,229,154
Income taxes note 3
--0 -
Net loss before dividends
-717,067 -690,913 -671,977 -1,229,154
Preferred stock dividends
431,000 81,410 82,316 89,392
Deemed dividends note 9
--0 -
Net loss attributable to common stockholders
-1,148,067 -772,323 -754,293 -1,318,546
Translation adjustment
-14,547 9,286 -36,169 76,680
Comprehensive loss
-1,162,614 -763,037 -790,462 -1,241,866
Loss per share, basic
-0.042 -0.029 -0.029 -0.054
Loss per share, diluted
-0.042 -0.029 -0.029 -0.054
Weighted average number of common shares outstanding - basic
27,590,766 26,767,370 26,284,734 24,232,369
Weighted average number of common shares outstanding - diluted
27,590,766 26,767,370 26,284,734 24,232,369
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$1,162,614 Device Sales$351,099 Technology Fees$3,636,720 Translation adjustment-$14,547 Net lossattributable to common...-$1,148,067 Revenue$3,987,819 Preferred stock dividends$431,000 Net loss beforedividends-$717,067 Gross profit$3,251,476 Cost of revenue$736,343 Net loss beforeincome taxes-$717,067 Gain/(loss) uponconvertible promissory...$11,409 (loss) profit fromoperations$440,915 Total operatingexpenses$2,810,561 Change in fair value ofderivative liabilities...-$134,335 Accretion andamortization expenses-$185,470 Interest expense$810,339 Otherincome/(expense)-$39,247 Research and developmentexpenses$623,567 Selling, general andadministrative expenses$2,186,994

BIOTRICITY INC. (BTCY)

BIOTRICITY INC. (BTCY)